With Healthcare Middlemen Controlling Prescription Drug Prices, There’s a Better Model for Pharmacy Care

Date: 5 Apr 2017 | posted in: Retail | 0 Facebooktwitterredditmail

There’s a small group of powerful companies, called pharmacy benefit managers, or PBMs, that increasingly controls the prices of prescription drugs. The results of this market power include higher costs, worse outcomes for patients, and diminishing competition. A new article in the American Prospect looks at the problem and what state and federal governments should do about it, including such solutions as North Dakota’s Pharmacy Ownership Law.… Read More